Medically Supervised Weight Loss and Wellness Programs

Tirzepatide Program

Tirzepatide is a medication that belongs to a class of drugs known as GLP-1 receptor agonists. It is used for the treatment of type 2 diabetes and weight loss.

By targeting both receptors, Tirzepatide enhances insulin secretion and reduces glucagon secretion in a glucose-dependent manner, contributing to improved glycemic control. In addition to its glucose-lowering effects, tirzepatide has been associated with significant weight loss in clinical trials. This can be particularly beneficial for individuals with type 2 diabetes, as weight management is a crucial aspect of overall diabetes care. Like other newer diabetes medications, tirzepatide has undergone cardiovascular outcomes trials. These trials assess the impact of the medication on cardiovascular events, providing valuable information on the safety and potential cardiovascular benefits of the drug.

Semaglutide Program

Semaglutide is a medication that belongs to a class of drugs known as GLP-1 receptor agonists. It is used to treat type 2 diabetes by regulating blood sugar levels.

Semaglutide is a medication that has emerged as a potentially effective option for weight loss in individuals who meet specific criteria. This is because it reduces appetite, slows down the emptying of the stomach, and increases feelings of fullness. It has shown promising results in clinical trials and offers a novel approach to weight management by influencing appetite and metabolism. However, it should be used under the guidance of a healthcare professional, and the benefits and risks should be carefully evaluated on an individual basis. Additionally, a holistic approach to weight management, including diet and exercise, should be considered alongside medication when seeking sustainable weight loss. Semaglutide is administered once a week by injection, which makes it more convenient than other diabetes medications that need to be taken several times a day. 

Retatrutide 

Next-Generation Weight Loss Therapy

Retatrutide is a cutting-edge GLP-1/GLP-2/GIP receptor agonist designed to support significant, sustainable weight loss. By targeting appetite regulation, metabolism, and glucose control, Retatrutide helps clients reduce body fat while preserving lean muscle mass.

Key Benefits:

  • Clinically shown to promote substantial weight reduction
  • Supports appetite control and healthier eating patterns
  • Improves metabolic health and insulin sensitivity
  • Administered via convenient, once-weekly subcutaneous injection

 

(INCLUDED IN ALL WEIGHT LOSS PROGRAM)

  • Free assessment with our weight loss specialist
  • 15 min KICKOFF session with nutritionist/personal trainer
  • Program Durations: 1, 3, or 6 months
  • Nutritional consultation
  • Exercise regiment 
  • Weekly check-in and tele-health

 

No products found
Use fewer filters or remove all

The offerings presented have not undergone assessment by the US Food and Drug Administration. These items are not designed to diagnose, remedy, mitigate, or avert any ailments. The content on this site is purely for informational objectives and shouldn't be taken as medical counsel. Always seek guidance from a medical professional prior to initiating any therapeutic regimen.